Hemodynamic predictors of mortality in adults with sickle cell disease.

BACKGROUND Pulmonary hypertension (PH) in adults with sickle cell disease (SCD) is associated with early mortality, but no prior studies have evaluated quantitative relationships of mortality to physiological measures of pre- and postcapillary PH. OBJECTIVES To identify risk factors associated with mortality and to estimate the expected survival in a cohort of patients with SCD with PH documented by right heart catheterization. METHODS Nine-year follow-up data (median, 4.7 yr) from the National Institutes of Health SCD PH screening study are reported. A total of 529 adults with SCD were screened by echocardiography between 2001 and 2010 with no exclusion criteria. Hemodynamic data were collected from 84 patients. PH was defined as mean pulmonary artery pressure (PAP) ≥ 25 mm Hg. Survival rates were estimated by the Kaplan-Meier method, and mortality risk factors were analyzed by the Cox proportional hazards regression. MEASUREMENTS AND MAIN RESULTS Specific hemodynamic variables were independently related to mortality: mean PAP (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.05-2.45 per 10 mm Hg increase; P = 0.027), diastolic PAP (HR, 1.83; 95% CI, 1.09-3.08 per 10 mm Hg increase; P = 0.022), diastolic PAP - pulmonary capillary wedge pressure (HR, 2.19; 95% CI, 1.23-3.89 per 10 mm Hg increase; P = 0.008), transpulmonary gradient (HR, 1.78; 95% CI, 1.14-2.79 per 10 mm Hg increase; P = 0.011), and pulmonary vascular resistance (HR, 1.44; 95% CI, 1.09-1.89 per Wood unit increase; P = 0.009) as risk factors for mortality. CONCLUSIONS Mortality in adults with SCD and PH is proportional to the physiological severity of precapillary PH, demonstrating its prognostic and clinical relevance despite anemia-induced high cardiac output and less severely elevated pulmonary vascular resistance.

[1]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[2]  J. Stockman,et al.  A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease , 2013 .

[3]  M. Gladwin,et al.  Mortality in adults with sickle cell disease and pulmonary hypertension. , 2012, JAMA.

[4]  G. Simonneau,et al.  Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different , 2012, European Respiratory Journal.

[5]  V. Salemi,et al.  Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease , 2011, European Respiratory Journal.

[6]  D. Spevack,et al.  An Elevated Estimated Pulmonary Arterial Systolic Pressure, Whenever Measured, Is Associated with Excess Mortality in Adults with Sickle Cell Disease , 2011, Acta Haematologica.

[7]  R. Hebbel Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine , 2011, American journal of hematology.

[8]  M. Gladwin,et al.  Hemodynamic Parameters Predict Mortality In Sickle Cell Disease-Related Pulmonary Hypertension , 2010 .

[9]  O. Platt,et al.  Pulmonary hypertension and nitric oxide depletion in sickle cell disease. , 2010, Blood.

[10]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[11]  Yutaka Takeda,et al.  Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension , 2010, BMC pulmonary medicine.

[12]  N. Lee,et al.  Diagnosis and assessment of pulmonary arterial hypertension , 2010 .

[13]  G. Simonneau [A new clinical classification of pulmonary hypertension]. , 2009, Bulletin de l'Academie nationale de medecine.

[14]  G. Kato,et al.  Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea , 2009, American journal of hematology.

[15]  L. Savale,et al.  Prevalence and Mechanism of Pulmonary Hypertension in Sickle Cell Disease: A Prospective Multicentre French Study. , 2009, ATS 2009.

[16]  F. Pashankar,et al.  Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease , 2009, British journal of haematology.

[17]  A. Zaiman,et al.  Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. , 2009, Arthritis and rheumatism.

[18]  M. Humbert,et al.  [Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension]. , 2008, La Revue du praticien.

[19]  M. Gladwin,et al.  Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive Pain , 2008, PloS one.

[20]  F. Roudot-thoraval,et al.  Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease at a Glance Commentary , 2022 .

[21]  A. Ashley-Koch,et al.  Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes , 2008, American journal of hematology.

[22]  M. Gladwin,et al.  Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency , 2008, American journal of hematology.

[23]  G. Simonneau,et al.  Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.

[24]  M. Cairo,et al.  Pulmonary hypertension in sickle cell disease. , 2007, Clinical advances in hematology & oncology : H&O.

[25]  Vandana Sachdev,et al.  Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. , 2007, American journal of respiratory and critical care medicine.

[26]  M. Mosunjac,et al.  Sickle Cell Lung Disease and Sudden Death: A Retrospective/Prospective Study of 21 Autopsy Cases and Literature Review , 2007, The American journal of forensic medicine and pathology.

[27]  M. Gladwin,et al.  PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children , 2007, Pediatric hematology and oncology.

[28]  M. Gladwin,et al.  Severity of pulmonary hypertension during vaso‐occlusive pain crisis and exercise in patients with sickle cell disease , 2007, British journal of haematology.

[29]  William O Ntim,et al.  Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. , 2007, Journal of the American College of Cardiology.

[30]  M. Gladwin,et al.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. , 2006, Circulation.

[31]  C. Moore,et al.  Pulmonary hypertension in patients with sickle cell disease: a longitudinal study , 2006, British journal of haematology.

[32]  Mark T Gladwin,et al.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. , 2005, Blood.

[33]  S. Kimmel,et al.  Hemodynamics and survival of patients with portopulmonary hypertension , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[34]  J. Krishnan,et al.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.

[35]  C. Denton,et al.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach , 2003, Annals of the rheumatic diseases.

[36]  Arvind K. Shah,et al.  Causes of death in sickle cell disease: an autopsy study , 2003, British journal of haematology.

[37]  O. Castro,et al.  Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. , 2003, Blood.

[38]  D. Chemla,et al.  Haemodynamic evaluation of pulmonary hypertension , 2002, European Respiratory Journal.

[39]  P. Adegboyega,et al.  Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. , 2002, Human pathology.

[40]  A. Shillington,et al.  Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.

[41]  Gilles Garcia,et al.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.

[42]  M. Gladwin,et al.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease , 2002, Nature Medicine.

[43]  M. Daly,et al.  Guilt by association , 2000, Nature Genetics.

[44]  R. Wiesner,et al.  Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  Stuart Rich,et al.  Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.

[46]  M. Fujita,et al.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.

[47]  P. Reddy,et al.  Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. , 1993, American heart journal.

[48]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[49]  N. Schiller,et al.  Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. , 1990, The American journal of cardiology.

[50]  J. Niland,et al.  Sickle Cell Chronic Lung Disease: Prior Morbidity and the Risk of Pulmonary Failure , 1988, Medicine.

[51]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[52]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[53]  E. Orringer,et al.  Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. , 1982, The American journal of medicine.

[54]  D. Wolfe,et al.  Nonparametric Statistical Methods. , 1974 .

[55]  H. Hellems,et al.  Hemodynamic Studies in Sickle Cell Anemia , 1954, Circulation.